RRC ID 77097
著者 Maradani BS, Parameswaran S, Subramanian K.
タイトル Development and characterization of DNA aptamer against Retinoblastoma by Cell-SELEX.
ジャーナル Sci Rep
Abstract Retinoblastoma (RB) is the most common paediatric intraocular tumour. The management of RB has improved the survival and vision with recent advances in the treatment. Improved therapeutic approaches focussing on targeting tumours and minimizing the treatment-associated side effects are being developed. In this study, we generated a ssDNA aptamer against RB by cell-SELEX and high-throughput sequencing using Weri-RB1 cell line as the target, and Muller glial cell line Mio-M1 as the control. Three aptamers were selected based on the number of repetitions in NGS and phylogenetic relationship and evaluated by flow cytometry to assess their binding affinity and selectivity. The dissociation constant, Kd values of three selected aptamers were found to be in the nanomolar range. Aptamer VRF-CSRB-01 with the best binding affinity and a Kd value of 49.41 ± 7.87 nM was further characterized. The proteinase and temperature treatment indicated that VRF-CSRB-01 targets surface proteins, and has a good binding affinity and excellent selectivity under physiological conditions. The aptamer VRF-CSRB-01 was stable over 72 h in serum and 96 h in cerebral spinal fluid and vitreous. With the high affinity, specificity, stability and specific recognition of clinical RB tumours, VRF-CSRB-01 aptamer holds potential for application in diagnosis and targeting RB.
巻・号 12(1)
ページ 16178
公開日 2022-9-28
DOI 10.1038/s41598-022-20660-3
PII 10.1038/s41598-022-20660-3
PMID 36171412
PMC PMC9519959
MeSH Aptamers, Nucleotide* / chemistry Child Humans Membrane Proteins / genetics Peptide Hydrolases / genetics Phylogeny Retinal Neoplasms* / genetics Retinoblastoma* / genetics SELEX Aptamer Technique
IF 3.998
リソース情報
ヒト・動物細胞 Y79(RCB1645) NCC-RbC-39(RCB2205) NCC-RbC-51(RCB2206) NCC-RbC-60(RCB2213) WERI-Rb-1(RCB2146)